This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Mar 1;383(9919):841-3.

doi: 10.1016/S0140-6736(13)62365-X.

Type 2 diabetes as a redox disease

James D Watson¹

Affiliations

PMID: 24581668
DOI: 10.1016/S0140-6736(13)62365-X

Type 2 diabetes as a redox disease

James D Watson. Lancet. 2014.

. 2014 Mar 1;383(9919):841-3.

doi: 10.1016/S0140-6736(13)62365-X.

Author

James D Watson¹

Affiliation

¹ Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. Electronic address: berejka@cshl.edu.

PMID: 24581668
DOI: 10.1016/S0140-6736(13)62365-X

No abstract available

PubMed Disclaimer

Comment in

Type 2 diabetes caused by reductive redox potential?
Liu X, Fang F. Liu X, et al. Sci China Life Sci. 2014 Jul;57(7):729-30. doi: 10.1007/s11427-014-4668-4. Epub 2014 May 15. Sci China Life Sci. 2014. PMID: 24829109 No abstract available.
Type 2 diabetes and cancer as redox diseases?
Erol A. Erol A. Lancet. 2014 Sep 6;384(9946):853-4. doi: 10.1016/S0140-6736(14)61486-0. Lancet. 2014. PMID: 25209482 No abstract available.
Type 2 diabetes and cancer as redox diseases?
Molenaar RJ, van Noorden CJ. Molenaar RJ, et al. Lancet. 2014 Sep 6;384(9946):853. doi: 10.1016/S0140-6736(14)61485-9. Lancet. 2014. PMID: 25209484 No abstract available.

Similar articles

Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes.
Mascitelli L, Pezzetta F, Goldstein MR. Mascitelli L, et al. Int J Clin Pract. 2009 Apr;63(4):672. doi: 10.1111/j.1742-1241.2008.01983.x. Int J Clin Pract. 2009. PMID: 19335710 No abstract available.
Metformin Activates AMPK through the Lysosomal Pathway.
Zhang CS, Li M, Ma T, Zong Y, Cui J, Feng JW, Wu YQ, Lin SY, Lin SC. Zhang CS, et al. Cell Metab. 2016 Oct 11;24(4):521-522. doi: 10.1016/j.cmet.2016.09.003. Cell Metab. 2016. PMID: 27732831 No abstract available.
Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.
Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M. Nasri H, et al. Iran J Kidney Dis. 2013 Nov;7(6):423-8. Iran J Kidney Dis. 2013. PMID: 24241085 Review.
Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
Cheang WS, Tian XY, Wong WT, Lau CW, Lee SS, Chen ZY, Yao X, Wang N, Huang Y. Cheang WS, et al. Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):830-6. doi: 10.1161/ATVBAHA.113.301938. Epub 2014 Jan 30. Arterioscler Thromb Vasc Biol. 2014. PMID: 24482374
Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity.
Friedrichsen M, Mortensen B, Pehmøller C, Birk JB, Wojtaszewski JF. Friedrichsen M, et al. Mol Cell Endocrinol. 2013 Feb 25;366(2):204-14. doi: 10.1016/j.mce.2012.06.013. Epub 2012 Jul 11. Mol Cell Endocrinol. 2013. PMID: 22796442 Review.

See all similar articles

Cited by

GSH levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapy.
Goutzourelas N, Orfanou M, Charizanis I, Leon G, Spandidos DA, Kouretas D. Goutzourelas N, et al. Exp Ther Med. 2018 Aug;16(2):635-642. doi: 10.3892/etm.2018.6204. Epub 2018 May 23. Exp Ther Med. 2018. PMID: 30116319 Free PMC article.
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D, Liu C, Qin M, Zhang X, Xi T, Yuan S, Hao H, Xiong J. Du D, et al. Acta Pharm Sin B. 2022 Feb;12(2):558-580. doi: 10.1016/j.apsb.2021.09.019. Epub 2021 Sep 25. Acta Pharm Sin B. 2022. PMID: 35256934 Free PMC article. Review.
Flaxseed Ethanol Extract Effect in Acute Experimental Inflammation.
Chera EI, Pop TI, Pop RM, Pârvu M, Uifălean A, Cătoi FA, Cecan AD, Mîrza CM, Achimaș-Cadariu P, Pârvu AE. Chera EI, et al. Medicina (Kaunas). 2022 Apr 24;58(5):582. doi: 10.3390/medicina58050582. Medicina (Kaunas). 2022. PMID: 35629999 Free PMC article.
Candidate genes associated with the effect of rosiglitazone on glycemic control and cardiovascular system in the treatment of type 2 diabetes mellitus.
Wu X. Wu X. Exp Ther Med. 2019 Mar;17(3):2039-2046. doi: 10.3892/etm.2019.7160. Epub 2019 Jan 9. Exp Ther Med. 2019. PMID: 30783475 Free PMC article.
Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.
Lee Y, Berglund ED, Yu X, Wang MY, Evans MR, Scherer PE, Holland WL, Charron MJ, Roth MG, Unger RH. Lee Y, et al. Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13217-22. doi: 10.1073/pnas.1409638111. Epub 2014 Aug 25. Proc Natl Acad Sci U S A. 2014. PMID: 25157166 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information